Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 102

1.

Role of CCL7 in Type I Hypersensitivity Reactions in Murine Experimental Allergic Conjunctivitis.

Kuo CH, Collins AM, Boettner DR, Yang Y, Ono SJ.

J Immunol. 2017 Jan 15;198(2):645-656. doi: 10.4049/jimmunol.1502416. Epub 2016 Dec 12.

2.

Serum inflammatory markers after rupture retinal laser injury in mice.

Paulus YM, Kuo CH, Morohoshi K, Nugent A, Zheng LL, Nomoto H, Blumenkranz MS, Palanker D, Ono SJ.

Ophthalmic Surg Lasers Imaging Retina. 2015 Mar;46(3):362-8. doi: 10.3928/23258160-20150323-11.

PMID:
25856824
3.

New twists to an old story: novel concepts in the pathogenesis of allergic eye disease.

Saban DR, Calder V, Kuo CH, Reyes NJ, Dartt DA, Ono SJ, Niederkorn JY.

Curr Eye Res. 2013 Mar;38(3):317-30. doi: 10.3109/02713683.2012.747617. Epub 2013 Jan 2. Review.

4.

The role of TRB3 in mast cells sensitized with monomeric IgE.

Kuo CH, Morohoshi K, Aye CC, Garoon RB, Collins A, Ono SJ.

Exp Mol Pathol. 2012 Dec;93(3):408-15. doi: 10.1016/j.yexmp.2012.09.008. Epub 2012 Sep 21.

PMID:
23000510
5.

The murine CCR3 receptor regulates both eosinophilia and hyperresponsiveness in IgE-mediated allergic conjunctivitis.

Fukuda K, Kuo CH, Morohoshi K, Liu FT, Ono SJ.

Br J Ophthalmol. 2012 Aug;96(8):1132-6. doi: 10.1136/bjophthalmol-2011-301399. Epub 2012 Jun 13.

PMID:
22694967
6.

Evidence that formation of vimentin mitogen-activated protein kinase (MAPK) complex mediates mast cell activation following FcεRI/CC chemokine receptor 1 cross-talk.

Toda M, Kuo CH, Borman SK, Richardson RM, Inoko A, Inagaki M, Collins A, Schneider K, Ono SJ.

J Biol Chem. 2012 Jul 13;287(29):24516-24. doi: 10.1074/jbc.M111.319624. Epub 2012 May 21.

7.

Identification of anti-retinal antibodies in patients with age-related macular degeneration.

Morohoshi K, Ohbayashi M, Patel N, Chong V, Bird AC, Ono SJ.

Exp Mol Pathol. 2012 Oct;93(2):193-9. doi: 10.1016/j.yexmp.2012.03.007. Epub 2012 Mar 19.

PMID:
22465421
8.

Identification of genes and proteins specifically regulated by costimulation of mast cell Fcε Receptor I and chemokine receptor 1.

Aye CC, Toda M, Morohoshi K, Ono SJ.

Exp Mol Pathol. 2012 Jun;92(3):267-74. doi: 10.1016/j.yexmp.2012.02.002. Epub 2012 Mar 7.

PMID:
22417871
9.

Serum autoantibody biomarkers for age-related macular degeneration and possible regulators of neovascularization.

Morohoshi K, Patel N, Ohbayashi M, Chong V, Grossniklaus HE, Bird AC, Ono SJ.

Exp Mol Pathol. 2012 Feb;92(1):64-73. doi: 10.1016/j.yexmp.2011.09.017. Epub 2011 Oct 6.

PMID:
22001380
10.

The effect of perioperative allergic conjunctivitis on corneal lymphangiogenesis after corneal transplantation.

Flynn TH, Ohbayashi M, Dawson M, Larkin DF, Ono SJ.

Br J Ophthalmol. 2011 Oct;95(10):1451-6. doi: 10.1136/bjo.2010.201939. Epub 2011 Jun 7.

PMID:
21653212
12.

Characterisation of the phenotype and function of monocyte-derived dendritic cells in allergic conjunctiva.

Manzouri B, Ohbayashi M, Leonardi A, Fattah D, Larkin DF, Ono SJ.

Br J Ophthalmol. 2010 Dec;94(12):1662-7. doi: 10.1136/bjo.2009.177774. Epub 2010 Aug 30.

PMID:
20805129
13.
14.

The role of histamine in ocular allergy.

Ohbayashi M, Manzouri B, Morohoshi K, Fukuda K, Ono SJ.

Adv Exp Med Biol. 2010;709:43-52. Review.

PMID:
21618886
15.

Autoimmunity in retinal degeneration: autoimmune retinopathy and age-related macular degeneration.

Morohoshi K, Goodwin AM, Ohbayashi M, Ono SJ.

J Autoimmun. 2009 Nov-Dec;33(3-4):247-54. doi: 10.1016/j.jaut.2009.09.003. Epub 2009 Oct 27. Review.

PMID:
19846275
16.

Use of ultrasonic pachymetry for measurement of changes in corneal thickness in mouse corneal transplant rejection.

Flynn TH, Ohbayashi M, Dawson M, Siddique M, Ono SJ, Larkin DF.

Br J Ophthalmol. 2010 Mar;94(3):368-71. doi: 10.1136/bjo.2009.160671. Epub 2009 Oct 12.

PMID:
19822919
17.

Critical role of IgE-dependent mast cell activation in a murine model of allergic conjunctivitis.

Fukuda K, Ohbayashi M, Morohoshi K, Zhang L, Liu FT, Ono SJ.

J Allergy Clin Immunol. 2009 Oct;124(4):827-33.e2. doi: 10.1016/j.jaci.2009.06.012. Epub 2009 Aug 5.

PMID:
19660804
18.

CCR1 expression and signal transduction by murine BMMC results in secretion of TNF-alpha, TGFbeta-1 and IL-6.

Fifadara NH, Aye CC, Raghuwanshi SK, Richardson RM, Ono SJ.

Int Immunol. 2009 Aug;21(8):991-1001. doi: 10.1093/intimm/dxp066. Epub 2009 Jul 10.

PMID:
19592420
19.

Expression of high mobility group A2 protein in retinoblastoma and its association with clinicopathologic features.

Venkatesan N, Kandalam M, Pasricha G, Sumantran V, Manfioletti G, Ono SJ, Reddy MA, Krishnakumar S.

J Pediatr Hematol Oncol. 2009 Mar;31(3):209-14. doi: 10.1097/MPH.0b013e318197978d.

PMID:
19262251
20.

Ablation of type I hypersensitivity in experimental allergic conjunctivitis by eotaxin-1/CCR3 blockade.

Miyazaki D, Nakamura T, Ohbayashi M, Kuo CH, Komatsu N, Yakura K, Tominaga T, Inoue Y, Higashi H, Murata M, Takeda S, Fukushima A, Liu FT, Rothenberg ME, Ono SJ.

Int Immunol. 2009 Feb;21(2):187-201. doi: 10.1093/intimm/dxn137. Epub 2009 Jan 15.

21.

Characterization of dendritic cell phenotype in allergic conjunctiva: increased expression of Fc(epsilon)RI, the high-affinity receptor for immunoglobulin E.

Manzouri B, Ohbayashi M, Leonardi A, Larkin DF, Ono SJ.

Eye (Lond). 2009 Nov;23(11):2099-104. doi: 10.1038/eye.2008.372. Epub 2008 Dec 19.

PMID:
19098700
22.

Regulatory function of CpG-activated B cells in late-phase experimental allergic conjunctivitis.

Miyazaki D, Kuo CH, Tominaga T, Inoue Y, Ono SJ.

Invest Ophthalmol Vis Sci. 2009 Apr;50(4):1626-35. doi: 10.1167/iovs.08-2701. Epub 2008 Dec 5.

PMID:
19060266
23.

Invariant chain+ N2a neuroblastoma cells stably expressing the class II MHC transactivator CIITA fail to stimulate anti-tumor immunity.

Rickard S, Ono SJ.

Exp Mol Pathol. 2008 Dec;85(3):147-54. doi: 10.1016/j.yexmp.2008.09.003. Epub 2008 Oct 8.

PMID:
18952077
24.

Increased mast cell numbers in the conjunctiva of glaucoma patients: a possible indicator of preoperative glaucoma surgery inflammation.

Chang L, Wong T, Ohbayashi M, Bunce C, Barton K, Ono SJ, Khaw PT.

Eye (Lond). 2009 Sep;23(9):1859-65. doi: 10.1038/eye.2008.330. Epub 2008 Oct 24. Erratum in: Eye (Lond). 2009 Nov;23(11):2136. Ono S [corrected to Ono SJ].

PMID:
18949008
25.

Conjunctival mast cell as a mediator of eosinophilic response in ocular allergy.

Miyazaki D, Tominaga T, Yakura K, Kuo CH, Komatsu N, Inoue Y, Ono SJ.

Mol Vis. 2008 Aug 22;14:1525-32.

26.

Aqueous humor alloreactive cell phenotypes, cytokines and chemokines in corneal allograft rejection.

Flynn TH, Mitchison NA, Ono SJ, Larkin DF.

Am J Transplant. 2008 Jul;8(7):1537-43. doi: 10.1111/j.1600-6143.2008.02285.x.

27.

A shot in the arm for mast cells.

Pulendran B, Ono SJ.

Nat Med. 2008 May;14(5):489-90. doi: 10.1038/nm0508-489. No abstract available.

PMID:
18463655
28.

The dendritic cell in allergic conjunctivitis.

Manzouri B, Flynn T, Ohbayashi M, Ono SJ.

Ocul Surf. 2008 Apr;6(2):70-8. Review.

PMID:
18418504
29.

Macular and retinal dysfunction of unknown origin in adults with normal fundi: evidence for an autoimmune pathophysiology.

Mantel I, Ramchand KV, Holder GE, Ohbayashi M, Morohoshi K, Patel N, Toda M, Fitzke FW, Bird AC, Ono SJ.

Exp Mol Pathol. 2008 Apr;84(2):90-101. doi: 10.1016/j.yexmp.2007.10.006. Epub 2007 Nov 9. Erratum in: Exp Mol Pathol. 2009 Oct;87(2):166.

PMID:
18255057
30.

Effect of allergic conjunctival inflammation on the allogeneic response to donor cornea.

Flynn TH, Ohbayashi M, Ikeda Y, Ono SJ, Larkin DF.

Invest Ophthalmol Vis Sci. 2007 Sep;48(9):4044-9.

PMID:
17724186
31.

Dynamic changes in conjunctival dendritic cell numbers, anatomical position and phenotype during experimental allergic conjunctivitis.

Ohbayashi M, Manzouri B, Flynn T, Toda M, Ikeda Y, Nakamura T, Ono SJ.

Exp Mol Pathol. 2007 Oct;83(2):216-23. Epub 2007 May 10.

PMID:
17560570
32.

Role of beta-chemokines in mast cell activation and type I hypersensitivity reactions in the conjunctiva: in vivo and in vitro studies.

Beer F, Kuo CH, Morohoshi K, Goodliffe J, Munro P, Aye CC, Dawson M, Richardson RM, Jones LH, Ikeda Y, Nakamura T, Toda M, Flynn T, Ohbayashi M, Miyazaki D, Ono SJ.

Immunol Rev. 2007 Jun;217:96-104. Review.

PMID:
17498054
33.

Mechanisms of leukocyte trafficking in allergic diseases: insights into new therapies targeting chemokines and chemokine receptors.

Toda M, Nakamura T, Ohbayashi M, Ikeda Y, Dawson M, Aye CC, Miyazaki D, Ono SJ.

Expert Rev Clin Immunol. 2007 May;3(3):351-64. doi: 10.1586/1744666X.3.3.351.

PMID:
20477679
34.

Allergy and contact lenses.

Siddique M, Manzouri B, Flynn TH, Ono SJ.

Chem Immunol Allergy. 2007;92:166-175. doi: 10.1159/000099267. Review.

PMID:
17264492
35.

Pharmacotherapy of allergic eye disease.

Manzouri B, Flynn TH, Larkin F, Ono SJ, Wyse R.

Expert Opin Pharmacother. 2006 Jun;7(9):1191-200. Review.

PMID:
16732705
36.

Inhibition of MHC class II gene expression in uveal melanoma cells is due to methylation of the CIITA gene or an upstream activator.

Radosevich M, Jager M, Ono SJ.

Exp Mol Pathol. 2007 Feb;82(1):68-76. Epub 2006 May 2.

PMID:
16650406
37.

Role of CC chemokines and their receptors in multiple aspects of mast cell biology: comparative protein profiling of FcepsilonRI- and/or CCR1-engaged mast cells using protein chip technology.

Toda M, Nakamura T, Ohbayashi M, Ikeda Y, Dawson M, Richardson RM, Alban A, Leed B, Miyazaki D, Ono SJ.

Novartis Found Symp. 2005;271:131-40; discussion 140-51.

PMID:
16605132
38.

A specific CCR3 chemokine receptor antagonist inhibits both early and late phase allergic inflammation in the conjunctiva.

Nakamura T, Ohbayashi M, Toda M, Hall DA, Horgan CM, Ono SJ.

Immunol Res. 2005;33(3):213-21.

PMID:
16461999
39.

Does the polymorphism of MHC class II promoters matter?

Mitchison NA, Ono SJ, Stephens HA.

Cell Immunol. 2005 Feb;233(2):162-5. Review.

PMID:
15953596
40.

Circulating anti-retinal antibodies as immune markers in age-related macular degeneration.

Patel N, Ohbayashi M, Nugent AK, Ramchand K, Toda M, Chau KY, Bunce C, Webster A, Bird AC, Ono SJ, Chong V.

Immunology. 2005 Jul;115(3):422-30.

41.

IFN-gamma gene expression is controlled by the architectural transcription factor HMGA1.

Chau KY, Keane-Myers AM, Fedele M, Ikeda Y, Creusot RJ, Menozzi L, Cousins DJ, Manfioletti G, Feigenbaum L, Fusco A, Ono SJ.

Int Immunol. 2005 Mar;17(3):297-306. Epub 2005 Feb 14.

PMID:
15710911
42.

Macrophage inflammatory protein-1alpha as a costimulatory signal for mast cell-mediated immediate hypersensitivity reactions.

Miyazaki D, Nakamura T, Toda M, Cheung-Chau KW, Richardson RM, Ono SJ.

J Clin Invest. 2005 Feb;115(2):434-42.

43.

Allergic conjunctivitis: update on pathophysiology and prospects for future treatment.

Ono SJ, Abelson MB.

J Allergy Clin Immunol. 2005 Jan;115(1):118-22. Review.

PMID:
15637556
44.
46.
47.

Roles of chemokines in ocular allergy and possible therapeutic strategies.

Miyazaki D, Nakamura T, Komatsu N, Nawata N, Ikeda Y, Inoue Y, Higashi H, Ono SJ.

Cornea. 2004 Nov;23(8 Suppl):S48-54. Review.

PMID:
15448480
48.

Impact of engagement of FcepsilonRI and CC chemokine receptor 1 on mast cell activation and motility.

Toda M, Dawson M, Nakamura T, Munro PM, Richardson RM, Bailly M, Ono SJ.

J Biol Chem. 2004 Nov 12;279(46):48443-8. Epub 2004 Aug 26.

49.

Epigenetic silencing of the CIITA gene and posttranscriptional regulation of class II MHC genes in ocular melanoma cells.

Radosevich M, Song Z, Gorga JC, Ksander B, Ono SJ.

Invest Ophthalmol Vis Sci. 2004 Sep;45(9):3185-95.

PMID:
15326139
50.

A CIITA-independent pathway that promotes expression of endogenous rather than exogenous peptides in immune-privileged sites.

Arancibia-Cárcamo CV, Osawa H, Arnett HA, Háskova Z, George AJ, Ono SJ, Ting JP, Streilein JW.

Eur J Immunol. 2004 Feb;34(2):471-80.

Supplemental Content

Support Center